We read with great interest the article by Gyldenkerne et al. (1), which was published in the January 2025 issue of Diabetes Care. We commend the authors for their insightful research on time trends in peripheral artery disease (PAD) among patients with incident type 2 diabetes (T2D). Their retrospective study, conducted in Denmark, highlights a significant decrease in the 5-year cumulative incidence of PAD (adjusted hazard ratio [aHR] 0.55 [95% CI 0.52–0.57]) between 1996–2000 and 2011–2015. T2D and PAD represent growing global health concerns, with important implications for cardiovascular and limb-related morbidity and mortality, quality of life, and health care resource use and costs (2). Diabetes is a recognized risk factor for PAD, and the occurrence of PAD in individuals with T2D serves to further increase the risk of long-term complications (2,3). The important study by Gyldenkerne et al. contributes valuable insights into the positive effects of improved diabetes management over time in the transition to the technology age.
Patiëntvoorbeelden m.b.t. vergoeding
- ten laste van verzekeraar
- geen vergoeding door verzekeraar